NEDD4 E3 ubiquitin ligases: Promising biomarkers and therapeutic targets for cancer
Biochemical Pharmacology · 2023-08 · 214 · 115641
DOI: 10.1016/j.bcp.2023.115641 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2023-08. Verfasst von Xianyan Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, China. Hauptthemen laut MEDLINE: Endosomal Sorting Complexes Required for Transport, Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 222 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Graduate Research and Innovation Projects of Jiangsu Province.
Abstract (Originalsprache)
Accumulating evidence has demonstrated that NEDD4 E3 ubiquitin ligase family plays a pivotal oncogenic role in a variety of malignancies via mediating ubiquitin dependent degradation processes. Moreover, aberrant expression of NEDD4 E3 ubiquitin ligases is often indicative of cancer progression and correlated with poor prognosis. In this review, we are going to address association of expression of NEDD4 E3 ubiquitin ligases with cancers, the signaling pathways and the molecular mechanisms by which the NEDD4 E3 ubiquitin ligases regulate oncogenesis and progression, and the therapies targeting the NEDD4 E3 ubiquitin ligases. This review provides the systematic and comprehensive summary of the latest research status of E3 ubiquitin ligases in the NEDD4 subfamily, and proposes that NEDD4 family E3 ubiquitin ligases are promising anti-cancer drug targets, aiming to provide research direction for clinical targeting of NEDD4 E3 ubiquitin ligase therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, China.
- School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, China. Electronic address: qlin@ujs.edu.cn.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Graduate Research and Innovation Projects of Jiangsu Province
Zitieren
APA
Tian, X., Chen, Y., Peng, Z., Lin, Q., & Sun, A. (2023). NEDD4 E3 ubiquitin ligases: Promising biomarkers and therapeutic targets for cancer. Biochemical Pharmacology, 214, 115641. https://doi.org/10.1016/j.bcp.2023.115641
Vancouver
Tian X, Chen Y, Peng Z, Lin Q, Sun A. NEDD4 E3 ubiquitin ligases: Promising biomarkers and therapeutic targets for cancer. Biochemical Pharmacology. 2023;214:115641. doi:10.1016/j.bcp.2023.115641
BibTeX
@article{Tian2023,
author = {Tian, Xianyan and Chen, Yifei and Peng, Ziluo and Lin, Qiong and Sun, Aiqin},
title = {NEDD4 E3 ubiquitin ligases: Promising biomarkers and therapeutic targets for cancer},
journal = {Biochemical Pharmacology},
year = {2023},
volume = {214},
pages = {115641},
doi = {10.1016/j.bcp.2023.115641}
}
EUVIMED